Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium
Compose a Response to This Article
Other responses
No responses have been published for this article.
